Nantahala Capital Management - Q1 2016 holdings

$972 Million is the total value of Nantahala Capital Management's 78 reported holdings in Q1 2016. The portfolio turnover from Q4 2015 to Q1 2016 was 31.3% .

 Value Shares↓ Weighting
IWM BuyISHARES TRput$236,750,000
+100.2%
2,140,000
+103.8%
24.36%
+57.9%
IWM NewISHARES TRcall$45,447,000410,800
+100.0%
4.68%
DRII BuyDIAMOND RESORTS INTL INC$44,909,000
+2.2%
1,848,127
+7.3%
4.62%
-19.4%
SGMS SellSCIENTIFIC GAMES CORPcall$43,361,000
-2.3%
4,598,200
-7.1%
4.46%
-23.0%
YHOO SellYAHOO INC$39,602,000
+7.9%
1,075,850
-2.5%
4.07%
-14.9%
DLB SellDOLBY LABORATORIES INC$36,498,000
+20.6%
839,807
-6.6%
3.76%
-4.9%
DRII NewDIAMOND RESORTS INTL INCcall$34,020,0001,400,000
+100.0%
3.50%
SGMS BuySCIENTIFIC GAMES CORPcl a$33,815,000
+12.3%
3,585,901
+6.8%
3.48%
-11.5%
FCFS SellFIRST CASH FINL SVCS INC$22,556,000
-16.7%
489,713
-32.3%
2.32%
-34.3%
SCLN BuySCICLONE PHARMACEUTICALS INC$22,277,000
+323.4%
2,025,150
+254.1%
2.29%
+234.1%
BPI BuyBRIDGEPOINT ED INC$22,196,000
+34.7%
2,201,945
+1.7%
2.28%
+6.2%
CASH BuyMETA FINL GROUP INC$21,487,000
+6.5%
471,198
+7.3%
2.21%
-16.0%
SODA BuySODASTREAM INTERNATIONAL LTD$19,864,000
-6.7%
1,410,806
+8.1%
2.04%
-26.4%
CTRN BuyCITI TRENDS INC$17,876,000
+10.3%
1,002,603
+31.5%
1.84%
-13.0%
CDXS BuyCODEXIS INC$15,595,000
-23.4%
5,014,509
+4.2%
1.60%
-39.6%
ORM SellOWENS RLTY MTG INC$15,074,000
+5.8%
943,890
-11.0%
1.55%
-16.5%
CROX BuyCROCS INC$14,969,000
+32.2%
1,555,996
+40.8%
1.54%
+4.3%
PTIE BuyPAIN THERAPEUTICS INC$14,349,000
+41.1%
6,434,498
+10.7%
1.48%
+11.2%
M NewMACYS INC$14,070,000319,112
+100.0%
1.45%
ARQL BuyARQULE INC$13,670,000
+6.6%
8,543,652
+44.6%
1.41%
-16.0%
SellIMPERIAL HLDS INCnote 8.500% 2/1$12,472,000
-4.1%
13,970,000
-5.4%
1.28%
-24.4%
AKBA BuyAKEBIA THERAPEUTICS INC$12,139,000
+323.8%
1,347,326
+507.8%
1.25%
+234.0%
CRWN SellCROWN MEDIA HLDGS INCcl a$11,558,000
-9.9%
2,275,217
-0.5%
1.19%
-28.9%
QADA BuyQAD INCcl a$10,297,000
+6.2%
484,560
+2.6%
1.06%
-16.3%
GDEN SellGOLDEN ENTMT INC$10,083,000
+3.0%
930,205
-2.8%
1.04%
-18.8%
RM SellREGIONAL MGMT CORP$9,873,000
+1.7%
577,024
-8.0%
1.02%
-19.7%
RLGT BuyRADIANT LOGISTICS INC$9,812,000
+11.1%
2,748,540
+6.7%
1.01%
-12.4%
RACE NewFERRARI N V$8,969,000215,082
+100.0%
0.92%
CSH SellCASH AMER INTL INC$8,820,000
-22.4%
228,262
-39.8%
0.91%
-38.8%
TBBK  BANCORP INC DEL$8,728,000
-10.2%
1,525,7870.0%0.90%
-29.2%
ESINQ BuyITT EDUCATIONAL SERVICES INC$8,712,000
-8.6%
2,819,288
+10.3%
0.90%
-27.9%
SIR SellSELECT INCOME REIT$8,424,000
+3.4%
365,457
-11.1%
0.87%
-18.4%
LXFR BuyLUXFER HLDGS PLCsponsored adr$8,394,000
+23.9%
791,155
+14.9%
0.86%
-2.3%
FCAU SellFIAT CHRYSLER AUTOMOBILES Ncall$8,060,000
-73.8%
1,000,000
-54.5%
0.83%
-79.4%
EMGCQ SellEMERGENT CAP INC$7,789,000
-5.1%
1,937,560
-12.9%
0.80%
-25.2%
TWMC SellTRANS WORLD ENTMT CORP$7,638,000
-7.2%
2,034,034
-11.5%
0.79%
-26.7%
PIP SellPHARMATHENE INC$6,390,000
-0.8%
3,251,838
-4.1%
0.66%
-21.8%
SXC SellSUNCOKE ENERGY INC$5,693,000
+71.2%
875,782
-8.6%
0.59%
+35.0%
FALC SellFALCONSTOR SOFTWARE INC$5,696,000
-35.1%
4,250,690
-9.0%
0.59%
-48.8%
SFR NewCOLONY STARWOOD HOMES$5,691,000229,951
+100.0%
0.58%
RBCAA SellREPUBLIC BANCORP KYcl a$5,466,000
-27.8%
211,624
-26.2%
0.56%
-43.1%
LINC BuyLINCOLN EDL SVCS CORP$5,335,000
+32.0%
2,151,049
+5.9%
0.55%
+4.2%
EPM BuyEVOLUTION PETROLEUM CORP$5,039,000
+12.9%
1,036,786
+11.7%
0.52%
-11.0%
FNTCU SellFINTECH ACQUISITION CORP*unit 99/99/9999$4,871,000
-19.7%
450,000
-25.0%
0.50%
-36.7%
FCAU SellFIAT CHRYSLER AUTOMOBILES N$4,739,000
-56.7%
587,952
-24.9%
0.49%
-65.8%
QADB SellQAD INCcl b$4,355,000
-8.5%
245,765
-5.0%
0.45%
-27.9%
BCOV SellBRIGHTCOVE INC$4,006,000
-19.1%
641,972
-19.6%
0.41%
-36.2%
REXI NewRESOURCE AMERICA INCcl a$3,987,000691,032
+100.0%
0.41%
SRPT NewSAREPTA THERAPEUTICS INCcall$3,904,000200,000
+100.0%
0.40%
USAK SellUSA TRUCK INC$2,920,000
-41.5%
154,996
-45.9%
0.30%
-54.0%
DVD SellDOVER MOTORSPORTS INC$2,835,000
-5.4%
1,248,903
-2.9%
0.29%
-25.3%
CGNT SellCOGENTIX MED INC$2,740,000
-18.1%
2,491,304
-4.0%
0.28%
-35.5%
WHF BuyWHITEHORSE FIN INC$2,446,000
+7.4%
235,669
+18.8%
0.25%
-15.2%
RYI NewRYERSON HLDG CORP$2,242,000403,226
+100.0%
0.23%
SellCASTLE A M & COnote 7.000/1$1,777,000
+21.5%
3,623,000
-4.7%
0.18%
-4.2%
RYAM NewRAYONIER ADVANCED MATLS INC$1,697,000178,651
+100.0%
0.18%
EZPW NewEZCORP INCcl a non vtg$1,675,000563,813
+100.0%
0.17%
GME SellGAMESTOP CORP NEWput$1,514,000
+8.0%
47,700
-4.6%
0.16%
-14.8%
SXCP  SUNCOKE ENERGY PARTNERS L P$1,385,000
-0.8%
187,3750.0%0.14%
-22.0%
UTI BuyUNIVERSAL TECHNICAL INST INC$867,000
-3.7%
201,187
+4.2%
0.09%
-23.9%
SGYPQ NewSYNERGY PHARMACEUTICALS DEL$828,000300,000
+100.0%
0.08%
MFCB BuyMFC BANCORP LTD$768,000
+158.6%
387,978
+154.5%
0.08%
+102.6%
PHMD BuyPHOTOMEDEX INC$748,000
+151.0%
1,384,777
+109.4%
0.08%
+97.4%
EMMS BuyEMMIS COMMUNICATIONS CORPcl a$720,000
-7.2%
1,237,562
+2.1%
0.07%
-26.7%
CVO SellCENVEO INC$564,000
-57.8%
1,247,162
-14.5%
0.06%
-66.7%
OCN SellOCWEN FINL CORPcall$459,000
-66.1%
186,000
-4.1%
0.05%
-73.3%
CASLQ SellCASTLE A M & CO$364,000
+7.7%
134,764
-36.6%
0.04%
-15.9%
DDE SellDOVER DOWNS GAMING & ENTMT I$201,000
+4.1%
187,970
-5.4%
0.02%
-16.0%
SODA ExitSODASTREAM INTERNATIONAL LTDcall$0-65,000
-100.0%
-0.14%
DYAX ExitDYAX CORP$0-48,873
-100.0%
-0.24%
DYAX ExitDYAX CORPput$0-51,000
-100.0%
-0.25%
NRC ExitNATIONAL RESH CORPcl a$0-142,454
-100.0%
-0.30%
INCY ExitINCYTE CORPcall$0-31,000
-100.0%
-0.44%
URI ExitUNITED RENTALS INCcall$0-54,200
-100.0%
-0.51%
GM ExitGENERAL MTRS COput$0-170,000
-100.0%
-0.75%
CROX ExitCROCS INCcall$0-576,900
-100.0%
-0.77%
F ExitFORD MTR CO DELput$0-560,000
-100.0%
-1.03%
ExitISIS PHARMACEUTICALS INC DELnote 2.750/0$0-2,500,000
-100.0%
-1.22%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2016-05-16
Signatures

The EDGAR filing(s) were signed by:

About Nantahala Capital Management

Nantahala Capital Management is a hedge fund that was founded in 2004 by Wil Harkey. The firm is headquartered in Connecticut and has additional offices in New York and North Carolina. Nantahala Capital Management primarily invests in the technology, healthcare, and consumer sectors. The firm has a long-term investment approach and seeks to identify undervalued companies with strong growth potential.

Wil Harkey serves as the CEO and Chief Investment Officer of Nantahala Capital Management. He has over 20 years of experience in the finance industry and previously worked at Goldman Sachs and Maverick Capital. In addition to Harkey, the firm's leadership team includes COO and General Counsel, David Kozak, and CFO, Michael Kozak.

Nantahala Capital Management has a strong track record of generating positive returns for its investors. The firm's flagship fund, the Nantahala Fund, has delivered an annualized return of over 20% since its inception in 2006. The firm's success can be attributed to its disciplined investment approach and focus on long-term value creation.

Overall, Nantahala Capital Management is a well-respected hedge fund with a talented leadership team and a strong track record of performance. However, as with any investment, it is important for investors to conduct their own due diligence and carefully consider the risks before investing in the firm's funds.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
ISHARES TR42Q3 202327.2%
CODEXIS INC42Q3 20233.9%
PATHWARD FINANCIAL INC35Q3 20236.3%
SCIENTIFIC GAMES CORP34Q3 20225.3%
DOVER MOTORSPORTS INC34Q3 20210.5%
GOLDEN ENTMT INC33Q3 20232.1%
QAD INC32Q3 20212.6%
SCIENTIFIC GAMES CORP31Q4 20217.7%
DOLBY LABORATORIES INC31Q4 20205.6%
LINCOLN EDL SVCS CORP31Q4 20210.7%

View Nantahala Capital Management's complete holdings history.

Latest significant ownerships (13-D/G)
Nantahala Capital Management Q1 2016 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
AYTU BIOPHARMA, INCJune 16, 20231,086,81219.7%
Acer Therapeutics Inc.February 14, 20231,226,1917.5%
Aeglea BioTherapeutics, Inc.February 14, 20234,611,3027.5%
AKUMIN INC.February 14, 20232,206,9602.5%
ALTA EQUIPMENT GROUP INC.February 14, 20231,188,9853.7%
Apollo Endosurgery, Inc.February 14, 20234,056,6279.9%
Autolus Therapeutics plcFebruary 14, 20237,782,0184.7%
Bioventus Inc.February 14, 20233,168,5745.1%
CATALYST BIOSCIENCES, INC.February 14, 2023438,0551.4%
Drive Shack Inc.February 14, 20236,500,0007.0%

View Nantahala Capital Management's complete significant-ownership history.

Latest filings
TypeFiled
42024-03-21
42024-03-15
SC 13G2024-03-11
13F-HR/A2024-02-15
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14

View Nantahala Capital Management's complete filings history.

Compare quarters

Export Nantahala Capital Management's holdings